nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Taste metallic—Methotrexate—systemic scleroderma	0.0142	0.0142	CcSEcCtD
Methocarbamol—Nasal congestion—Pentoxifylline—systemic scleroderma	0.0135	0.0135	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Azathioprine—systemic scleroderma	0.0127	0.0127	CcSEcCtD
Methocarbamol—Nasal congestion—Mometasone—systemic scleroderma	0.0116	0.0116	CcSEcCtD
Methocarbamol—Injury—Mometasone—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Mycophenolic acid—systemic scleroderma	0.0115	0.0115	CcSEcCtD
Methocarbamol—Trauma—Prednisone—systemic scleroderma	0.0113	0.0113	CcSEcCtD
Methocarbamol—Nystagmus—Mycophenolate mofetil—systemic scleroderma	0.0111	0.0111	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Lisinopril—systemic scleroderma	0.0103	0.0103	CcSEcCtD
Methocarbamol—Drowsiness—Pentoxifylline—systemic scleroderma	0.00947	0.00947	CcSEcCtD
Methocarbamol—Jaundice—Pentoxifylline—systemic scleroderma	0.00923	0.00923	CcSEcCtD
Methocarbamol—Conjunctivitis—Pentoxifylline—systemic scleroderma	0.00921	0.00921	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Mycophenolate mofetil—systemic scleroderma	0.00906	0.00906	CcSEcCtD
Methocarbamol—Lightheadedness—Lisinopril—systemic scleroderma	0.00813	0.00813	CcSEcCtD
Methocarbamol—Injury—Mycophenolic acid—systemic scleroderma	0.00797	0.00797	CcSEcCtD
Methocarbamol—Conjunctivitis—Mometasone—systemic scleroderma	0.00795	0.00795	CcSEcCtD
Methocarbamol—Flushing—Pentoxifylline—systemic scleroderma	0.00789	0.00789	CcSEcCtD
Methocarbamol—Dysgeusia—Pentoxifylline—systemic scleroderma	0.00725	0.00725	CcSEcCtD
Methocarbamol—Nasal congestion—Lisinopril—systemic scleroderma	0.00724	0.00724	CcSEcCtD
Methocarbamol—Injury—Lisinopril—systemic scleroderma	0.00718	0.00718	CcSEcCtD
Methocarbamol—Jaundice—Captopril—systemic scleroderma	0.007	0.007	CcSEcCtD
Methocarbamol—Vision blurred—Pentoxifylline—systemic scleroderma	0.00698	0.00698	CcSEcCtD
Methocarbamol—Angioedema—Pentoxifylline—systemic scleroderma	0.00676	0.00676	CcSEcCtD
Methocarbamol—Thrombophlebitis—Mycophenolate mofetil—systemic scleroderma	0.00668	0.00668	CcSEcCtD
Methocarbamol—Leukopenia—Pentoxifylline—systemic scleroderma	0.00663	0.00663	CcSEcCtD
Methocarbamol—Diplopia—Lisinopril—systemic scleroderma	0.0066	0.0066	CcSEcCtD
Methocarbamol—Convulsion—Pentoxifylline—systemic scleroderma	0.00641	0.00641	CcSEcCtD
Methocarbamol—Injury—Mycophenolate mofetil—systemic scleroderma	0.00629	0.00629	CcSEcCtD
Methocarbamol—Amnesia—Mycophenolate mofetil—systemic scleroderma	0.00615	0.00615	CcSEcCtD
Methocarbamol—Confusional state—Pentoxifylline—systemic scleroderma	0.00609	0.00609	CcSEcCtD
Methocarbamol—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00604	0.00604	CcSEcCtD
Methocarbamol—Flushing—Captopril—systemic scleroderma	0.00598	0.00598	CcSEcCtD
Methocarbamol—Shock—Pentoxifylline—systemic scleroderma	0.00594	0.00594	CcSEcCtD
Methocarbamol—Angioedema—Mometasone—systemic scleroderma	0.00584	0.00584	CcSEcCtD
Methocarbamol—Diplopia—Mycophenolate mofetil—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Methocarbamol—Jaundice—Leflunomide—systemic scleroderma	0.00577	0.00577	CcSEcCtD
Methocarbamol—Conjunctivitis—Leflunomide—systemic scleroderma	0.00575	0.00575	CcSEcCtD
Methocarbamol—Hypotension—Pentoxifylline—systemic scleroderma	0.00565	0.00565	CcSEcCtD
Methocarbamol—Jaundice—Mycophenolic acid—systemic scleroderma	0.0055	0.0055	CcSEcCtD
Methocarbamol—Dysgeusia—Captopril—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Methocarbamol—Conjunctivitis—Mycophenolic acid—systemic scleroderma	0.00549	0.00549	CcSEcCtD
Methocarbamol—Insomnia—Pentoxifylline—systemic scleroderma	0.00546	0.00546	CcSEcCtD
Methocarbamol—Somnolence—Pentoxifylline—systemic scleroderma	0.00537	0.00537	CcSEcCtD
Methocarbamol—Dyspepsia—Pentoxifylline—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Methocarbamol—Vision blurred—Captopril—systemic scleroderma	0.00529	0.00529	CcSEcCtD
Methocarbamol—Anaphylactic shock—Mometasone—systemic scleroderma	0.00521	0.00521	CcSEcCtD
Methocarbamol—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00516	0.00516	CcSEcCtD
Methocarbamol—Angioedema—Captopril—systemic scleroderma	0.00513	0.00513	CcSEcCtD
Methocarbamol—Syncope—Captopril—systemic scleroderma	0.00503	0.00503	CcSEcCtD
Methocarbamol—Feeling abnormal—Pentoxifylline—systemic scleroderma	0.00498	0.00498	CcSEcCtD
Methocarbamol—Jaundice—Lisinopril—systemic scleroderma	0.00496	0.00496	CcSEcCtD
Methocarbamol—Loss of consciousness—Captopril—systemic scleroderma	0.00493	0.00493	CcSEcCtD
Methocarbamol—Urticaria—Pentoxifylline—systemic scleroderma	0.0048	0.0048	CcSEcCtD
Methocarbamol—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00478	0.00478	CcSEcCtD
Methocarbamol—Bradycardia—Lisinopril—systemic scleroderma	0.00465	0.00465	CcSEcCtD
Methocarbamol—Confusional state—Captopril—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Methocarbamol—Dyspepsia—Mometasone—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Methocarbamol—Anaphylactic shock—Captopril—systemic scleroderma	0.00458	0.00458	CcSEcCtD
Methocarbamol—Dysgeusia—Leflunomide—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Methocarbamol—Thrombophlebitis—Prednisone—systemic scleroderma	0.00453	0.00453	CcSEcCtD
Methocarbamol—Shock—Captopril—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Methocarbamol—Pain—Mometasone—systemic scleroderma	0.00446	0.00446	CcSEcCtD
Methocarbamol—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00445	0.00445	CcSEcCtD
Methocarbamol—Leukopenia—Azathioprine—systemic scleroderma	0.00438	0.00438	CcSEcCtD
Methocarbamol—Vision blurred—Leflunomide—systemic scleroderma	0.00436	0.00436	CcSEcCtD
Methocarbamol—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.00434	0.00434	CcSEcCtD
Methocarbamol—Conjunctivitis—Mycophenolate mofetil—systemic scleroderma	0.00433	0.00433	CcSEcCtD
Methocarbamol—Hypotension—Captopril—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Methocarbamol—Pruritus—Pentoxifylline—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Methocarbamol—Injury—Prednisone—systemic scleroderma	0.00426	0.00426	CcSEcCtD
Methocarbamol—Flushing—Lisinopril—systemic scleroderma	0.00424	0.00424	CcSEcCtD
Methocarbamol—Angioedema—Leflunomide—systemic scleroderma	0.00423	0.00423	CcSEcCtD
Methocarbamol—Amnesia—Prednisone—systemic scleroderma	0.00417	0.00417	CcSEcCtD
Methocarbamol—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00416	0.00416	CcSEcCtD
Methocarbamol—Vertigo—Leflunomide—systemic scleroderma	0.00415	0.00415	CcSEcCtD
Methocarbamol—Insomnia—Captopril—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Methocarbamol—Leukopenia—Leflunomide—systemic scleroderma	0.00414	0.00414	CcSEcCtD
Methocarbamol—Body temperature increased—Mometasone—systemic scleroderma	0.00412	0.00412	CcSEcCtD
Methocarbamol—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Methocarbamol—Somnolence—Captopril—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Methocarbamol—Dyspepsia—Captopril—systemic scleroderma	0.00403	0.00403	CcSEcCtD
Methocarbamol—Dizziness—Pentoxifylline—systemic scleroderma	0.004	0.004	CcSEcCtD
Methocarbamol—Vertigo—Mycophenolic acid—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Methocarbamol—Syncope—Mycophenolic acid—systemic scleroderma	0.00396	0.00396	CcSEcCtD
Methocarbamol—Leukopenia—Mycophenolic acid—systemic scleroderma	0.00395	0.00395	CcSEcCtD
Methocarbamol—Dysgeusia—Lisinopril—systemic scleroderma	0.00389	0.00389	CcSEcCtD
Methocarbamol—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Methocarbamol—Vomiting—Pentoxifylline—systemic scleroderma	0.00384	0.00384	CcSEcCtD
Methocarbamol—Convulsion—Mycophenolic acid—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Methocarbamol—Rash—Pentoxifylline—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Methocarbamol—Dermatitis—Pentoxifylline—systemic scleroderma	0.00381	0.00381	CcSEcCtD
Methocarbamol—Headache—Pentoxifylline—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Methocarbamol—Thrombophlebitis—Methotrexate—systemic scleroderma	0.00378	0.00378	CcSEcCtD
Methocarbamol—Anaphylactic shock—Leflunomide—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Methocarbamol—Feeling abnormal—Captopril—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Methocarbamol—Vision blurred—Lisinopril—systemic scleroderma	0.00374	0.00374	CcSEcCtD
Methocarbamol—Hypotension—Azathioprine—systemic scleroderma	0.00373	0.00373	CcSEcCtD
Methocarbamol—Pruritus—Mometasone—systemic scleroderma	0.00369	0.00369	CcSEcCtD
Methocarbamol—Angioedema—Lisinopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Methocarbamol—Confusional state—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Methocarbamol—Body temperature increased—Captopril—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Methocarbamol—Nausea—Pentoxifylline—systemic scleroderma	0.00359	0.00359	CcSEcCtD
Methocarbamol—Vertigo—Lisinopril—systemic scleroderma	0.00357	0.00357	CcSEcCtD
Methocarbamol—Syncope—Lisinopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Methocarbamol—Leukopenia—Lisinopril—systemic scleroderma	0.00356	0.00356	CcSEcCtD
Methocarbamol—Shock—Mycophenolic acid—systemic scleroderma	0.00354	0.00354	CcSEcCtD
Methocarbamol—Hypotension—Leflunomide—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Methocarbamol—Loss of consciousness—Lisinopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Methocarbamol—Insomnia—Leflunomide—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Methocarbamol—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	0.00341	0.00341	CcSEcCtD
Methocarbamol—Hypotension—Mycophenolic acid—systemic scleroderma	0.00336	0.00336	CcSEcCtD
Methocarbamol—Dyspepsia—Leflunomide—systemic scleroderma	0.00332	0.00332	CcSEcCtD
Methocarbamol—Vomiting—Mometasone—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Methocarbamol—Feeling abnormal—Azathioprine—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Methocarbamol—Rash—Mometasone—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Methocarbamol—Dermatitis—Mometasone—systemic scleroderma	0.00328	0.00328	CcSEcCtD
Methocarbamol—Confusional state—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Methocarbamol—Headache—Mometasone—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Methocarbamol—Insomnia—Mycophenolic acid—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Methocarbamol—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Methocarbamol—Pruritus—Captopril—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Methocarbamol—Pain—Leflunomide—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Methocarbamol—Somnolence—Mycophenolic acid—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Methocarbamol—Shock—Lisinopril—systemic scleroderma	0.00319	0.00319	CcSEcCtD
Methocarbamol—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Methocarbamol—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Methocarbamol—Body temperature increased—Azathioprine—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Methocarbamol—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Methocarbamol—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Methocarbamol—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Methocarbamol—Feeling abnormal—Leflunomide—systemic scleroderma	0.00311	0.00311	CcSEcCtD
Methocarbamol—Nausea—Mometasone—systemic scleroderma	0.0031	0.0031	CcSEcCtD
Methocarbamol—Pain—Mycophenolic acid—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Methocarbamol—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00306	0.00306	CcSEcCtD
Methocarbamol—Hypotension—Lisinopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Methocarbamol—Dizziness—Captopril—systemic scleroderma	0.00303	0.00303	CcSEcCtD
Methocarbamol—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Methocarbamol—Urticaria—Leflunomide—systemic scleroderma	0.003	0.003	CcSEcCtD
Methocarbamol—Body temperature increased—Leflunomide—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Methocarbamol—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00297	0.00297	CcSEcCtD
Methocarbamol—Hypersensitivity—Azathioprine—systemic scleroderma	0.00294	0.00294	CcSEcCtD
Methocarbamol—Insomnia—Lisinopril—systemic scleroderma	0.00293	0.00293	CcSEcCtD
Methocarbamol—Vomiting—Captopril—systemic scleroderma	0.00291	0.00291	CcSEcCtD
Methocarbamol—Rash—Captopril—systemic scleroderma	0.00289	0.00289	CcSEcCtD
Methocarbamol—Dermatitis—Captopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Methocarbamol—Somnolence—Lisinopril—systemic scleroderma	0.00288	0.00288	CcSEcCtD
Methocarbamol—Headache—Captopril—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Methocarbamol—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Methocarbamol—Dyspepsia—Lisinopril—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Methocarbamol—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Methocarbamol—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00284	0.00284	CcSEcCtD
Methocarbamol—Shock—Mycophenolate mofetil—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Methocarbamol—Hypersensitivity—Leflunomide—systemic scleroderma	0.00278	0.00278	CcSEcCtD
Methocarbamol—Pain—Lisinopril—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Methocarbamol—Bradycardia—Prednisone—systemic scleroderma	0.00276	0.00276	CcSEcCtD
Methocarbamol—Nausea—Captopril—systemic scleroderma	0.00272	0.00272	CcSEcCtD
Methocarbamol—Feeling abnormal—Lisinopril—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Methocarbamol—Pruritus—Leflunomide—systemic scleroderma	0.00267	0.00267	CcSEcCtD
Methocarbamol—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Methocarbamol—Dizziness—Azathioprine—systemic scleroderma	0.00264	0.00264	CcSEcCtD
Methocarbamol—Urticaria—Lisinopril—systemic scleroderma	0.00258	0.00258	CcSEcCtD
Methocarbamol—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Methocarbamol—Body temperature increased—Lisinopril—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Methocarbamol—Pruritus—Mycophenolic acid—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Methocarbamol—Vomiting—Azathioprine—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Methocarbamol—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Methocarbamol—Drowsiness—Methotrexate—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Methocarbamol—Rash—Azathioprine—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Methocarbamol—Dermatitis—Azathioprine—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Methocarbamol—Flushing—Prednisone—systemic scleroderma	0.00252	0.00252	CcSEcCtD
Methocarbamol—Headache—Azathioprine—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Methocarbamol—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Methocarbamol—Dizziness—Leflunomide—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Methocarbamol—Conjunctivitis—Methotrexate—systemic scleroderma	0.00245	0.00245	CcSEcCtD
Methocarbamol—Pain—Mycophenolate mofetil—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Methocarbamol—Vomiting—Leflunomide—systemic scleroderma	0.0024	0.0024	CcSEcCtD
Methocarbamol—Hypersensitivity—Lisinopril—systemic scleroderma	0.00239	0.00239	CcSEcCtD
Methocarbamol—Dizziness—Mycophenolic acid—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Methocarbamol—Rash—Leflunomide—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Methocarbamol—Dermatitis—Leflunomide—systemic scleroderma	0.00238	0.00238	CcSEcCtD
Methocarbamol—Nausea—Azathioprine—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Methocarbamol—Headache—Leflunomide—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Methocarbamol—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Methocarbamol—Pruritus—Lisinopril—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Methocarbamol—Vomiting—Mycophenolic acid—systemic scleroderma	0.00229	0.00229	CcSEcCtD
Methocarbamol—Rash—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Methocarbamol—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00227	0.00227	CcSEcCtD
Methocarbamol—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Methocarbamol—Headache—Mycophenolic acid—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Methocarbamol—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Methocarbamol—Nausea—Leflunomide—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Methocarbamol—Vision blurred—Prednisone—systemic scleroderma	0.00222	0.00222	CcSEcCtD
Methocarbamol—Angioedema—Prednisone—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Methocarbamol—Dizziness—Lisinopril—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Methocarbamol—Nausea—Mycophenolic acid—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Methocarbamol—Vertigo—Prednisone—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Methocarbamol—Syncope—Prednisone—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Methocarbamol—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00209	0.00209	CcSEcCtD
Methocarbamol—Loss of consciousness—Prednisone—systemic scleroderma	0.00207	0.00207	CcSEcCtD
Methocarbamol—Vomiting—Lisinopril—systemic scleroderma	0.00206	0.00206	CcSEcCtD
Methocarbamol—Rash—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Methocarbamol—Convulsion—Prednisone—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Methocarbamol—Dermatitis—Lisinopril—systemic scleroderma	0.00204	0.00204	CcSEcCtD
Methocarbamol—Headache—Lisinopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Methocarbamol—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Methocarbamol—Dysgeusia—Methotrexate—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Methocarbamol—Nausea—Lisinopril—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Methocarbamol—Anaphylactic shock—Prednisone—systemic scleroderma	0.00193	0.00193	CcSEcCtD
Methocarbamol—Shock—Prednisone—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Methocarbamol—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00188	0.00188	CcSEcCtD
Methocarbamol—Vision blurred—Methotrexate—systemic scleroderma	0.00186	0.00186	CcSEcCtD
Methocarbamol—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Methocarbamol—Rash—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Methocarbamol—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Methocarbamol—Headache—Mycophenolate mofetil—systemic scleroderma	0.00178	0.00178	CcSEcCtD
Methocarbamol—Vertigo—Methotrexate—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Methocarbamol—Leukopenia—Methotrexate—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Methocarbamol—Insomnia—Prednisone—systemic scleroderma	0.00174	0.00174	CcSEcCtD
Methocarbamol—Convulsion—Methotrexate—systemic scleroderma	0.00171	0.00171	CcSEcCtD
Methocarbamol—Dyspepsia—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Methocarbamol—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00169	0.00169	CcSEcCtD
Methocarbamol—Confusional state—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Methocarbamol—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Methocarbamol—Feeling abnormal—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Methocarbamol—Urticaria—Prednisone—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Methocarbamol—Body temperature increased—Prednisone—systemic scleroderma	0.00152	0.00152	CcSEcCtD
Methocarbamol—Hypotension—Methotrexate—systemic scleroderma	0.0015	0.0015	CcSEcCtD
Methocarbamol—Insomnia—Methotrexate—systemic scleroderma	0.00146	0.00146	CcSEcCtD
Methocarbamol—Somnolence—Methotrexate—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Methocarbamol—Hypersensitivity—Prednisone—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Methocarbamol—Dyspepsia—Methotrexate—systemic scleroderma	0.00142	0.00142	CcSEcCtD
Methocarbamol—Pain—Methotrexate—systemic scleroderma	0.00138	0.00138	CcSEcCtD
Methocarbamol—Pruritus—Prednisone—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Methocarbamol—Feeling abnormal—Methotrexate—systemic scleroderma	0.00133	0.00133	CcSEcCtD
Methocarbamol—Urticaria—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Methocarbamol—Dizziness—Prednisone—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Methocarbamol—Body temperature increased—Methotrexate—systemic scleroderma	0.00127	0.00127	CcSEcCtD
Methocarbamol—Vomiting—Prednisone—systemic scleroderma	0.00122	0.00122	CcSEcCtD
Methocarbamol—Rash—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Methocarbamol—Dermatitis—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Methocarbamol—Headache—Prednisone—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Methocarbamol—Hypersensitivity—Methotrexate—systemic scleroderma	0.00119	0.00119	CcSEcCtD
Methocarbamol—Nausea—Prednisone—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Methocarbamol—Pruritus—Methotrexate—systemic scleroderma	0.00114	0.00114	CcSEcCtD
Methocarbamol—Dizziness—Methotrexate—systemic scleroderma	0.00106	0.00106	CcSEcCtD
Methocarbamol—Vomiting—Methotrexate—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Methocarbamol—Rash—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Methocarbamol—Dermatitis—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Methocarbamol—Headache—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Methocarbamol—Nausea—Methotrexate—systemic scleroderma	0.000956	0.000956	CcSEcCtD
